These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

595 related items for PubMed ID: 16330675

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sequential chemotherapy and irradiation in advanced stage endometrial cancer: A Gynecologic Oncology Group phase I trial of doxorubicin-cisplatin followed by whole abdomen irradiation.
    Fowler JM, Brady WE, Grigsby PW, Cohn DE, Mannel RS, Rader JS.
    Gynecol Oncol; 2009 Mar; 112(3):553-7. PubMed ID: 19135232
    [Abstract] [Full Text] [Related]

  • 3. Feasibility study of concurrent weekly cisplatin and whole abdominopelvic irradiation followed by doxorubicin/cisplatin chemotherapy for advanced stage endometrial carcinoma: a Gynecologic Oncology Group trial.
    Soper JT, Reisinger SA, Ashbury R, Jones E, Clarke-Pearson DL.
    Gynecol Oncol; 2004 Oct; 95(1):95-100. PubMed ID: 15385116
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.
    Fleming GF, Brunetto VL, Cella D, Look KY, Reid GC, Munkarah AR, Kline R, Burger RA, Goodman A, Burks RT.
    J Clin Oncol; 2004 Jun 01; 22(11):2159-66. PubMed ID: 15169803
    [Abstract] [Full Text] [Related]

  • 6. Whole abdominal radiotherapy versus combination chemotherapy with doxorubicin and cisplatin in advanced endometrial carcinoma (phase III): Gynecologic Oncology Group Study No. 122.
    Randall ME, Spirtos NM, Dvoretsky P.
    J Natl Cancer Inst Monogr; 1995 Jun 01; (19):13-5. PubMed ID: 7577198
    [Abstract] [Full Text] [Related]

  • 7. Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study.
    Thigpen JT, Brady MF, Homesley HD, Malfetano J, DuBeshter B, Burger RA, Liao S.
    J Clin Oncol; 2004 Oct 01; 22(19):3902-8. PubMed ID: 15459211
    [Abstract] [Full Text] [Related]

  • 8. Whole abdominal irradiation in endometrial cancer - a single institution study.
    Gocheva L, Slavchev B.
    J BUON; 2009 Oct 01; 14(4):613-8. PubMed ID: 20148451
    [Abstract] [Full Text] [Related]

  • 9. The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study.
    McMeekin DS, Filiaci VL, Thigpen JT, Gallion HH, Fleming GF, Rodgers WH, Gynecologic Oncology Group study.
    Gynecol Oncol; 2007 Jul 01; 106(1):16-22. PubMed ID: 17574073
    [Abstract] [Full Text] [Related]

  • 10. Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study.
    Tewari KS, Filiaci VL, Spirtos NM, Mannel RS, Thigpen JT, Cibull ML, Monk BJ, Randall ME.
    Gynecol Oncol; 2012 Apr 01; 125(1):87-93. PubMed ID: 22155678
    [Abstract] [Full Text] [Related]

  • 11. Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study.
    Modesitt SC, Tian C, Kryscio R, Thigpen JT, Randall ME, Gallion HH, Fleming GF, Gynecologic Oncology Group.
    Gynecol Oncol; 2007 Apr 01; 105(1):59-65. PubMed ID: 17150247
    [Abstract] [Full Text] [Related]

  • 12. Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium.
    Long HJ, Nelimark RA, Podratz KC, Suman V, Keeney GL, Nikcevich DA, Kugler JW, Rowland KM, Kardinal CG, Wos EJ.
    Gynecol Oncol; 2006 Mar 01; 100(3):501-5. PubMed ID: 16185755
    [Abstract] [Full Text] [Related]

  • 13. Phase I trial of the treatment of high-risk endometrial cancer with concurrent weekly paclitaxel and cisplatin and whole abdominal radiation therapy: a Gynecologic Oncology Group study.
    McMeekin DS, Walker JL, Hartenbach EM, Bookman MA, Koh WJ, Gynecologic Oncology Group.
    Gynecol Oncol; 2009 Jan 01; 112(1):134-41. PubMed ID: 18962846
    [Abstract] [Full Text] [Related]

  • 14. Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients.
    Bruzzone M, Miglietta L, Franzone P, Gadducci A, Boccardo F.
    Gynecol Oncol; 2004 May 01; 93(2):345-52. PubMed ID: 15099944
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the efficacy between paclitaxel/carboplatin and doxorubicin/cisplatin for concurrent chemoradiation in intermediate- or high-risk endometrioid endometrial cancer: a single institution experience.
    Kim HS, Kim JW, Wu HG, Chung HH, Park NH, Song YS, Kang SB, Lee HP.
    J Obstet Gynaecol Res; 2010 Jun 01; 36(3):598-604. PubMed ID: 20598043
    [Abstract] [Full Text] [Related]

  • 16. [A feasibility study of doxorubicin/cisplatin (AP) for postoperative chemotherapy in patients with advanced endometrial cancer].
    Nishio S, Katsumata N, Tanabe H, Matsumoto K, Yonemori K, Kouno T, Shimizu C, Ando M, Fujiwara Y.
    Gan To Kagaku Ryoho; 2006 Nov 01; 33(11):1589-93. PubMed ID: 17108724
    [Abstract] [Full Text] [Related]

  • 17. Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma.
    Burke TW, Gershenson DM, Morris M, Stringer CA, Levenback C, Tortolero-Luna G, Baker VV.
    Gynecol Oncol; 1994 Oct 01; 55(1):47-50. PubMed ID: 7959265
    [Abstract] [Full Text] [Related]

  • 18. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.
    Long HJ, Bundy BN, Grendys EC, Benda JA, McMeekin DS, Sorosky J, Miller DS, Eaton LA, Fiorica JV, Gynecologic Oncology Group Study.
    J Clin Oncol; 2005 Jul 20; 23(21):4626-33. PubMed ID: 15911865
    [Abstract] [Full Text] [Related]

  • 19. Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy.
    Kuoppala T, Mäenpää J, Tomas E, Puistola U, Salmi T, Grenman S, Lehtovirta P, Fors M, Luukkaala T, Sipilä P.
    Gynecol Oncol; 2008 Aug 20; 110(2):190-5. PubMed ID: 18534669
    [Abstract] [Full Text] [Related]

  • 20. Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent endometrial carcinoma.
    Long HJ, Langdon RM, Cha SS, Veeder MH, Pfeifle DM, Krook JE, Ebbert LP, Tschetter LK, Roshon SG.
    Gynecol Oncol; 1995 Aug 20; 58(2):240-3. PubMed ID: 7622111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.